sorafenib,bevacizumab,atezolizumab,veliparib,pembrolizumab
nrg oncology,roche,bayer,merck,abbvie
[]
nrg oncology research presentations start today at #gi23! oral presentations for nrg-rtog 1112 &amp; nrg-gi002; and poster presentations for nrg-gi004 (commit study), nrg-gi005 (cobra study), &amp; nrg-gi008 (circulate-us study). click here for the schedule: 
Advancing cancer research, improving lives.